4//SEC Filing
Karachun Rita A 4
Accession 0001127602-23-014739
CIK 0000310158other
Filed
May 4, 8:00 PM ET
Accepted
May 5, 4:54 PM ET
Size
19.2 KB
Accession
0001127602-23-014739
Insider Transaction Report
Form 4
Karachun Rita A
Sr. VP Fince-Global Controller
Transactions
- Tax Payment
Common Stock
2023-05-03$117.89/sh−276$32,538→ 45,086.972 total - Exercise/Conversion
Common Stock
2023-05-03$117.89/sh+803$94,666→ 45,362.972 total - Exercise/Conversion
Common Stock
2023-05-04$118.22/sh+949$112,191→ 46,035.972 total - Tax Payment
Common Stock
2023-05-04$118.22/sh−326$38,540→ 45,709.972 total - Exercise/Conversion
Common Stock
2023-05-04$62.07/sh+15,875$985,361→ 61,584.972 total - Sale
Common Stock
2023-05-04$117.53/sh−15,875$1,865,843→ 45,709.972 total - Exercise/Conversion
Restricted Stock Unit
2023-05-03−803→ 1,608 totalFrom: 2023-05-03Exp: 2025-05-03→ Common Stock (803 underlying) - Exercise/Conversion
Restricted Stock Unit
2023-05-04−949→ 951 totalFrom: 2022-05-04Exp: 2024-05-04→ Common Stock (949 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2023-05-04−15,875→ 0 totalExercise: $62.07From: 2018-05-05Exp: 2027-05-04→ Common Stock (15,875 underlying)
Footnotes (5)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.5000 to $117.6200, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- [F3]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2023, 5/3/2024 and 5/3/2025.
- [F4]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.
- [F5]The option became exercisable in equal installments on 5/5/2018, 5/5/2019 and 5/5/2020.
Documents
Issuer
Merck & Co., Inc.
CIK 0000310158
Entity typeother
Related Parties
1- filerCIK 0001601572
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 4:54 PM ET
- Size
- 19.2 KB